Results
76,350 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 15 | Buonasera DavidCHIEF TECHNOLOGY OFFICER |  MGNIMAGNITE, INC.Open-market sale · 10b5-1 plan | SELL | $22K 871 sh | Aug 7, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 15 | Buonasera DavidCHIEF TECHNOLOGY OFFICER | MGNIMAGNITE, INC. Open-market sale · 10b5-1 plan | SELL | $22K 871 sh | Aug 7, 2026 |
| 15 | Flammer Martina M.D.Chief Medical Officer |  INSMINSMED IncOpen-market sale · 10b5-1 plan | SELL | $2.37M 18.3K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 15 | Fego Paul JSVP, Global Operations |  QRVOQorvo, Inc.Tax withholding | F | $375K 3,944 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 15 | Kelly-Gemmell Dorothy ElizabethDirector |  VKTXViking Therapeutics, Inc.Grant or award | A | — 40.8K sh | Aug 7, 2026 traded Aug 1, 2026 |
| 15 | Hoffman Christina MarieSr. VP & Chief Risk Officer |  DGICADONEGAL GROUP INCOption exercise | M | $259K 18.0K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 15 | Kelly-Gemmell Dorothy ElizabethDirector | VKTXViking Therapeutics, Inc. Grant or award | A | — 6,333 sh | Aug 7, 2026 traded Aug 1, 2026 |
| 15 | Viljoen NataschaDirector, President & CEO |  NEMNEWMONT Corp /DE/Open-market sale · 10b5-1 plan | SELL | $807K 7,764 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 15 | Creviston Steven ESVP, Connectivity & Sensors | QRVOQorvo, Inc. Tax withholding | F | $375K 3,949 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 15 | Garis Douglas MichaelEVP&CFO |  CTEVClaritev CorpTax withholding | F | $306K 11.7K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 15 | Hopmans JohnEVP, M&A and Strategic Finance |  LYVLive Nation Entertainment, Inc.Tax withholding | F | $722K 3,970 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 14 | Bruggeworth Robert ADirector, President and CEO | QRVOQorvo, Inc. Tax withholding | F | $1.56M 16.4K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Gallagher CindyCAO |  TDAYUSA TODAY Co., Inc.Option exercise | M | — 9,592 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Gallagher CindyCAO | TDAYUSA TODAY Co., Inc. Option exercise | M | — 9,070 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 13 | Bonnefoy LucPresident, Surgical |  BLCOBausch & Lomb CorpGrant or award | A | — 16.8K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Eldessouky SamEVP and CFO | BLCOBausch & Lomb Corp Grant or award | A | — 50.3K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Lazar David E.Director, Chief Executive Officer, 10% Owner |  QUCYQuantum Cyber N.V.Derivative conversion | C | — 124.7K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Rudyk James DanielDirector |  CRONCronos Group Inc.Grant or award | A | — 48.9K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 13 | Gosser TrishaCFO | TDAYUSA TODAY Co., Inc. Option exercise | M | — 10.4K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 13 | Stewart Andrew J.President, GPIC | BLCOBausch & Lomb Corp Grant or award | A | — 16.8K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Alclear Investments, LLCDirector, 10% Owner, See Remarks |  YOUClear Secure, Inc.Open-market sale · 10b5-1 plan | SELL | $154K 2,430 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Xu ZhenyuChief Scientific Officer |  SOPHSOPHiA GENETICS SAOpen-market sale · 10b5-1 plan | SELL | $21K 3,000 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Munsch FrederickSVP, Controller and CAO | BLCOBausch & Lomb Corp Grant or award | A | — 9,091 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | YOUClear Secure, Inc. Open-market sale · 10b5-1 plan | SELL | $74K 1,200 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | YOUClear Secure, Inc. Open-market sale · 10b5-1 plan | SELL | $202K 3,096 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Xu ZhenyuChief Scientific Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $49K 7,000 sh | Aug 7, 2026 traded Aug 7, 2026 |
| 13 | Hashad YehiaEVP of R&D and CMO | BLCOBausch & Lomb Corp Grant or award | A | — 21.0K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Bailey A Robert DEVP & Chief Legal Officer | BLCOBausch & Lomb Corp Grant or award | A | — 33.6K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 12 | Stewart Frank P.SVP, Advanced Cellular | QRVOQorvo, Inc. Tax withholding | F | $215K 2,262 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 12 | Quinton SashaEVP, Pres. CBG |  SCHLSCHOLASTIC CORPOption exercise | M | $156K 7,549 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 12 | Saunders Brent LDirector, Chairman of the Board and CEO | BLCOBausch & Lomb Corp Tax withholding | F | $71K 4,231 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 12 | Olson DustinDirector, Chief Executive Officer |  PCTPureCycle Technologies, Inc.Tax withholding | F | $77K 11.1K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 11 | Medway Richard A.General Counsel |  SVVSavers Value Village, Inc.Option exercise · 10b5-1 plan | M | $14K 10.0K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 11 | Feierstein Matthew DavidPresident |  EVCMEverCommerce Inc.Open-market sale · 10b5-1 plan | SELL | $51K 5,000 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 11 | Medway Richard A.General Counsel | SVVSavers Value Village, Inc. Option exercise · 10b5-1 plan | M | $14K 10.0K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 11 | Flammer Martina M.D.Chief Medical Officer | INSMINSMED Inc Open-market sale · 10b5-1 plan | SELL | $1.13M 8,895 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 11 | Geisser Melinda L.Chief People Services Officer | SVVSavers Value Village, Inc. Option exercise · 10b5-1 plan | M | $21K 15.0K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 10 | Medway Richard A.General Counsel | SVVSavers Value Village, Inc. Option exercise · 10b5-1 plan | M | $53K 16.7K sh | Aug 7, 2026 traded Aug 7, 2026 |
| 10 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | YOUClear Secure, Inc. Open-market sale · 10b5-1 plan | SELL | $34K 500 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 10 | Walsh Mark T.Director, CEO & Director | SVVSavers Value Village, Inc. Option exercise · 10b5-1 plan | M | $158K 50.0K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 10 | O'Brien Michael GrahamCFO |  GTMZoomInfo Technologies Inc.Open-market sale · 10b5-1 plan | SELL | $20K 5,000 sh | Aug 7, 2026 traded Aug 6, 2026 |